DHMRI is proud to be the home of Discovery MS, a research program that is advancing the understanding of the origins of MS and improving diagnosis, prediction of disease progression, and assessment of treatment efficacy for MS. Led by DHMRI Genomics Director Simon Gregory, PhD,
Discovery MS taps the full range of scientific capabilities at DHMRI, which have contributed to novel findings including a unique metabolic signature and new insight into immune functionality in MS patients.
Learn more about Discovery MS.
The David H. Murdock Research Institute (DHMRI) Genomics Laboratory features a range of services and platforms that assist our collaborators with all phases of their projects from DNA or RNA extraction to library preparation and next generation sequencing. Our Genomics Laboratory also provides microarray and quantitative PCR platforms. Our scientists’ expertise allows them to develop novel methods, assays and protocols that give our collaborators custom applications and technologies. All of the work conducted in the Genomics Laboratory is supported by state-of-the art computational and bioinformatics resources that help our collaborators get the most from their genetic data.
Collaborators also benefit from the availability of complementary services provided by DHMRI laboratories that specialize in metabolomics, proteomics, NMR, microscopy and targeted biochemistry.